The sixth Nationwide Tuberculosis Prevalence Survey in Korea, 1990

Tuber Lung Dis. 1993 Oct;74(5):323-31. doi: 10.1016/0962-8479(93)90107-9.

Abstract

Setting: Nationwide random sample survey for tuberculosis in 1990.

Objective: To investigate the prevalence of tuberculosis infection, morbidity and drug resistance and BCG coverage, and to compare the findings with those of the previous 5 surveys.

Design: The following investigations were performed: tuberculin test, BCG scar screening, chest miniature radiography (70 mm x 70 mm) for those aged over 5 years, sputum direct smear, culture and drug susceptibility test, and a questionnaire to obtain history of chemotherapy and symptoms.

Results: The coverage of the investigation has been of more than 95% in each survey. The main findings are as follows: BCG coverage of those aged under 30 and of infants (aged under 1 year) has increased from 24% to 86% and from 1% to 79% respectively. The observed tuberculin positivity (> or = 10 mm in diameter) of subjects aged under 30 has decreased from 45% to 27%. The reduction of positivity was significant in children aged 5-9 years, from 34% to 8%. The annual risk of infection has dropped by over 6% annually. The prevalence of pulmonary tuberculosis per 100,000 has decreased: direct smear-positive from 690-143, smear and/or culture positive from 940-241 and active cases from 5065-1842 respectively. The drug resistance rate had increased to the peak of 47% in 1980, but had decreased to 27% in the last survey.

Conclusion: The tuberculosis situation has improved significantly in every aspect in the last 25 years.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • BCG Vaccine
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Female
  • Humans
  • Korea / epidemiology
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects
  • Prevalence
  • Random Allocation
  • Risk
  • Tuberculin Test
  • Tuberculosis / epidemiology*
  • Tuberculosis / prevention & control
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology

Substances

  • BCG Vaccine